| Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt s lymphoma. | lymphoma, |
| c-myc oncogene family expression in glioblastoma and survival. | glioblastoma, |
| [Study on relationship between proto-oncogene expression of c-fos and c-myc in airway, lung tissue and asthma in guinea pigs]. | lung, |
| Activation of the N-myc2 oncogene by woodchuck hepatitis virus integration in the linked downstream b3n locus in woodchuck hepatocellular carcinoma. | liver, |
| Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. | skin, |
| Oncogene expression cloning by retroviral transduction of adenovirus E1A-immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c-MYC and the zinc finger protein GKLF. | kidney, |
| Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma. | skin, |
| Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc. | lymphoma, |
| Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer. | prostate, |
| [Closely relationship between expression of endoplasmic reticulum molecular chaperone Grp94 and c-myc oncogene in human colorectal carcinoma cell lines]. | colorectal, |
| Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt s lymphoma cell lines. | lymphoma, |
| Amplification of the c-myc oncogene in non-small cell lung cancer. | lung, |
| Mapping of the oncogene c-myc (MYC) and the breast cancer susceptibility gene (BRCA2) in the pig by FISH. | breast, |
| Elevated levels of RanBP7 mRNA in colorectal carcinoma are associated with increased proliferation and are similar to the transcription pattern of the proto-oncogene c-myc. | colorectal, |
| Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein. | prostate, |
| c-myc oncogene gene dosage, serum CEA and CA-15.3 antigen levels, and cellular DNA values in relation to ex vivo chemosensitivity of primary human breast cancer. | breast, |
| Relationship of c-myc and erbB oncogene family gene aberrations and other selected factors to ex vivo chemosensitivity of ovarian cancer in the modified ATP-chemosensitivity assay. | ovarian, |
| The N-myc oncogene in human neuroblastoma cells: down-regulation of an angiogenesis inhibitor identified as activin A. | neuroblastoma, |
| Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. | skin, |
| Ongoing hypermutation in the Ig V(D)J gene segments and c-myc proto-oncogene of an AIDS lymphoma segregates with neoplastic B cells at different sites: implications for clonal evolution. | lymphoma, |